Wellnex Life Limited (ASX: WNX) - Share Price

Current share price for WNX : $0.090 0.015 (14.29%)⁺

Wellnex Life Limited (WNX) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is involved in the development, marketing and selling of premium brands and products for the growing health and pharmaceutical market and licensing of our unique and innovative product to domestic and global pharmaceutical companies.

WNX General Information ⁺

ASX Code	WNX
Website	http://wellnexlife.com.au
Industry/Sector	Packaged Foods & Meats
Market Cap ($M)	6
WNX Share Price	$0.090
Day High	$0.091
Day Low	$0.090
Last Close	$0.105
WNX Share Price Movement	$0.02 ( 14.29% )

Prices as at 13:05, 11 Aug 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

Wellnex Life Limited (WNX) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield

See all dividends from Wellnex Life Limited (WNX) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Wellnex Life Limited (WNX) price-sensitive announcements

WNX - Sale of Pain Away for up to A$21.3 million

Wellnex Life Limited has entered into a binding agreement to sell its Pain Away business a

Wellnex Life Limited (WNX)
6 Aug 2026 | 4:35 PM

WNX - Appendix 4C and Quarterly Report for Jun 2026 Quarter

Wellnex Life Limited's Appendix 4C for the June 2026 quarter highlights a second consecuti

Wellnex Life Limited (WNX)
31 Jul 2026 | 2:11 PM

WNX - Appendix 4C and Quarterly Report for Mar 2026 Quarter

Wellnex Life Limited has reported a significant milestone for the March 2026 quarter by ac

Wellnex Life Limited (WNX)
30 Apr 2026 | 4:19 PM

WNX - Extension of Loan Repayment

Wellnex Life Limited (ASX/AIM: WNX) announced an extension for the repayment of loans to f

Wellnex Life Limited (WNX)
23 Apr 2026 | 9:03 AM

Wellnex Life Limited (WNX) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Wellnex Life Limited (WNX) ORDINARY FULLY PAID	Consumer Staple	$7	Notice of Extraordinary General Meeting/Proxy Form	7 Aug 2026 3:30PM	$0.115	$0.090	fallen by 21.74%
Wellnex Life Limited (WNX) ORDINARY FULLY PAID	Consumer Staple	$7	Sale of Pain Away for up to A$21.3 million	6 Aug 2026 4:35PM	$0.055	$0.090	risen by 63.64%
Wellnex Life Limited (WNX) ORDINARY FULLY PAID	Consumer Staple	$7	Appendix 4C and Quarterly Report for Jun 2026 Quarter	31 Jul 2026 2:11PM	$0.052	$0.090	risen by 73.08%
Wellnex Life Limited (WNX) ORDINARY FULLY PAID	Consumer Staple	$7	Initial Director's Interest Notice	12 Jun 2026 6:30PM	$0.047	$0.090	risen by 91.49%
Wellnex Life Limited (WNX) ORDINARY FULLY PAID	Consumer Staple	$7	Appointment of Non-Executive Director	12 Jun 2026 6:28PM	$0.047	$0.090	risen by 91.49%
Wellnex Life Limited (WNX) ORDINARY FULLY PAID	Consumer Staple	$7	Appendix 4C and Quarterly Report for Mar 2026 Quarter	30 Apr 2026 4:19PM	$0.075	$0.090	risen by 20%

WNX Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	Yield (%)	Franking (%)
2025A	-$11.80	-$40.30	-12.80%	0.00%	0.0%
2024A	-$8.68	-$46.20	-49.60%	0.00%	0.0%
2023A	-$9.82	-$91.70	14.50%	0.00%	0.0%

WNX Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2023 A	2024 A	2025 A	2023 A	2024 A	2025 A	2023 A	2024 A	2025 A
The a2 Milk Company Limited (A2M)	$4,955M	0.2253	-0.1348	0.2603	26.3808	30.4911	24.1941	2.72%	2.32%	2.93%
Bega Cheese Limited (BGA)	$1,867M	-3.1132	0.0000	0.1754	0.0000	26.1334	22.2344	1.96%	2.45%	2.78%
Cobram Estate Olives Limited (CBO)	$1,690M	1.6604	0.0000	0.0000	31.0739	0.0000	0.0000	0.00%	0.00%	0.00%
Ricegrowers Limited (SGLLV)	$969M	-0.0114	-0.1992	0.1951	13.6719	17.0732	14.2857	5.00%	5.00%	5.00%
Wellnex Life Limited (WNX)	$8M	-0.1276	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%

WNX Market Comparison

	Earnings	P/E Ratio	P/B Ratio	P/E Growth
Company	0.00	0.00	0.63	0.00
Market	0.31	13.10	1.15	0.69
Sector	0.32	13.80	0.72	0.85

WNX Directors

Name	Position	Start Date
Mr Eric Jiang	Executive Director, Interim Chairman	13 Sep 2016
Mr Jeffrey Yeh	Non-Executive Director	15 Jan 2024
Mr Ash Vesali	Non-Executive Director	18 Sep 2025
Mr Hilton Keith Wood	Non-Executive Director	12 Jun 2026

Wellnex Life Limited (WNX) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
5 Mar 2025	BOZINOVSKI, Zlatko (Zack)	Issued	Indirect Shares	184,615	$0.650	$120,000.000
5 Mar 2025	YEH, Jeffrey	Issued	Indirect Shares	1,999,999	$0.650	$1,300,000.000
5 Mar 2025	KARAFOTIAS, George	Issued	Direct Shares	68,064	$0.650	$44,242.000

See all changes in directors' interest & trades for Wellnex Life Limited (WNX) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

WNX Management

Name	Position
Zheng (Kobe) Li	Company Secretary

WNX Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Wellnex Life Limited (WNX). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
3,427,010 (5.06%)	Homart Group Pty Ltd

WNX Calendar of Events

Date	Event
26 February 2027	Report (Interim)
29 September 2026	Report (Annual)
28 August 2026	Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us